DE68918847D1 - Stabile pharmazeutische zusammensetzung. - Google Patents

Stabile pharmazeutische zusammensetzung.

Info

Publication number
DE68918847D1
DE68918847D1 DE68918847T DE68918847T DE68918847D1 DE 68918847 D1 DE68918847 D1 DE 68918847D1 DE 68918847 T DE68918847 T DE 68918847T DE 68918847 T DE68918847 T DE 68918847T DE 68918847 D1 DE68918847 D1 DE 68918847D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
stable pharmaceutical
stable
composition
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68918847T
Other languages
English (en)
Other versions
DE68918847T2 (de
Inventor
Leonard Rosenberg
Cheryl Black
Earl SPEICHER
Dietmar Wagenknecht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson Infusion Therapy UK
Original Assignee
Ohmeda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohmeda filed Critical Ohmeda
Publication of DE68918847D1 publication Critical patent/DE68918847D1/de
Application granted granted Critical
Publication of DE68918847T2 publication Critical patent/DE68918847T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE68918847T 1988-06-08 1989-05-04 Stabile pharmazeutische zusammensetzung. Expired - Fee Related DE68918847T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/203,836 US4857552A (en) 1988-06-08 1988-06-08 Stable pharmaceutical composition
PCT/US1989/001834 WO1989011855A1 (en) 1988-06-08 1989-05-04 Stable pharmaceutical composition

Publications (2)

Publication Number Publication Date
DE68918847D1 true DE68918847D1 (de) 1994-11-17
DE68918847T2 DE68918847T2 (de) 1995-03-16

Family

ID=22755531

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68918847T Expired - Fee Related DE68918847T2 (de) 1988-06-08 1989-05-04 Stabile pharmazeutische zusammensetzung.

Country Status (13)

Country Link
US (1) US4857552A (de)
EP (1) EP0403578B1 (de)
JP (1) JP2552372B2 (de)
AU (1) AU613196B2 (de)
CA (1) CA1334001C (de)
DE (1) DE68918847T2 (de)
DK (1) DK32490A (de)
HU (1) HUT54041A (de)
IL (1) IL90551A (de)
MY (1) MY104030A (de)
NZ (1) NZ229410A (de)
WO (1) WO1989011855A1 (de)
ZA (1) ZA894344B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5405376A (en) * 1993-08-27 1995-04-11 Medtronic, Inc. Method and apparatus for ablation
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
AU758370B2 (en) * 1997-08-08 2003-03-20 Duke University Compositions, apparatus and methods for facilitating surgical procedures
TWI277414B (en) * 2001-01-12 2007-04-01 Baxter Int Esmolol formulation
US6310094B1 (en) * 2001-01-12 2001-10-30 Baxter International Inc. Ready-to-use esmolol solution
MXPA04002446A (es) 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
EP1417962A1 (de) 2002-11-06 2004-05-12 AOP Orphan Pharmaceuticals AG Verfahren zur Herstellung eines Arzneimittels enthaltend Esmolol
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
AU2014203121B2 (en) * 2007-05-22 2016-04-21 Baxter Healthcare Sa Concentrate esmolol
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
DK2234614T3 (da) 2007-12-21 2013-02-11 Aop Orphan Pharmaceuticals Ag Farmaceutisk sammensætning til parenteral administration af et ultrakort virkende beta-receptorblokerende middel
WO2011039780A2 (en) 2009-09-22 2011-04-07 Vlife Sciences Technologies Pvt. Ltd. Topical formulation for diabetic foot ulcers
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
HUE032486T2 (en) * 2009-12-18 2018-05-02 Metabolic Tech Inc An improved method for administering beta-hydroxy-beta-methylbutyrate (HMB)
CA2825311A1 (en) * 2011-01-27 2012-08-02 Baxter International Inc. Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension
BR112013018598A2 (pt) * 2011-01-27 2016-10-18 Baxter Healthcare Sa composição farmacêutica, método para tratar uma doença cardíaca, uso de (s)-metil-3-[4-(2-hidroxi-3-[4-(2-hidroxi-3-isopropilamino) propoxi] fenilpropionato, e, método para controlar frequência cardíaca
US8835505B1 (en) * 2013-03-15 2014-09-16 Welgrace Research Group Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container
CN104473869A (zh) * 2014-11-20 2015-04-01 北京京科泰来科技有限公司 一种艾司洛尔脂肪乳及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
WO1985004580A1 (en) * 1984-04-09 1985-10-24 American Hospital Supply Corporation Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders

Also Published As

Publication number Publication date
AU613196B2 (en) 1991-07-25
NZ229410A (en) 1991-10-25
MY104030A (en) 1993-10-30
AU3570489A (en) 1990-01-05
HU892994D0 (en) 1990-11-28
WO1989011855A1 (en) 1989-12-14
ZA894344B (en) 1991-02-27
DK32490D0 (da) 1990-02-07
EP0403578B1 (de) 1994-10-12
DE68918847T2 (de) 1995-03-16
HUT54041A (en) 1991-01-28
JPH03500658A (ja) 1991-02-14
EP0403578A1 (de) 1990-12-27
IL90551A (en) 1992-12-01
DK32490A (da) 1990-02-07
JP2552372B2 (ja) 1996-11-13
EP0403578A4 (en) 1991-07-03
CA1334001C (en) 1995-01-17
US4857552A (en) 1989-08-15
IL90551A0 (en) 1990-01-18

Similar Documents

Publication Publication Date Title
DE68901417D1 (de) Pharmazeutische zusammensetzung.
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
DE68911473D1 (de) Arzneimittelformulierungen.
DE69101931T2 (de) Pharmazeutische Zusammensetzung.
ATA129892A (de) Pharmazeutische zusammensetzung
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A (fi) Farmaceutiska kompositioner.
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
DE69006094T2 (de) Pharmazeutische Zusammensetzungen.
DE3485408D1 (de) Pharmazeutische zusammensetzung.
DE68918847T2 (de) Stabile pharmazeutische zusammensetzung.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
FI893643A0 (fi) Farmaceutiska kompositioner.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
DE4294862T1 (de) Pharmazeutische Komposition
DE68915203D1 (de) Pharmazeutische Mischungen.
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
DE68907609D1 (de) Arzneimittelzusammensetzung.
DE58905160D1 (de) Pharmazeutische zubereitung.
ATE78161T1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
DE69003003T2 (de) Pharmazeutische Zusammensetzung.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee